These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

577 related articles for article (PubMed ID: 25644835)

  • 1. Whole-epigenome analysis in multiple myeloma reveals DNA hypermethylation of B cell-specific enhancers.
    Agirre X; Castellano G; Pascual M; Heath S; Kulis M; Segura V; Bergmann A; Esteve A; Merkel A; Raineri E; Agueda L; Blanc J; Richardson D; Clarke L; Datta A; Russiñol N; Queirós AC; Beekman R; Rodríguez-Madoz JR; San José-Enériz E; Fang F; Gutiérrez NC; García-Verdugo JM; Robson MI; Schirmer EC; Guruceaga E; Martens JH; Gut M; Calasanz MJ; Flicek P; Siebert R; Campo E; Miguel JF; Melnick A; Stunnenberg HG; Gut IG; Prosper F; Martín-Subero JI
    Genome Res; 2015 Apr; 25(4):478-87. PubMed ID: 25644835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypermethylated LTR retrotransposon exhibits enhancer activity.
    Hu T; Zhu X; Pi W; Yu M; Shi H; Tuan D
    Epigenetics; 2017 Mar; 12(3):226-237. PubMed ID: 28165867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA Methylation of Intragenic CpG Islands are Required for Differentiation from iPSC to NPC.
    Choi WY; Hwang JH; Cho AN; Lee AJ; Lee J; Jung I; Cho SW; Kim LK; Kim YJ
    Stem Cell Rev Rep; 2020 Dec; 16(6):1316-1327. PubMed ID: 32975781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intragenic CpG islands play important roles in bivalent chromatin assembly of developmental genes.
    Lee SM; Lee J; Noh KM; Choi WY; Jeon S; Oh GT; Kim-Ha J; Jin Y; Cho SW; Kim YJ
    Proc Natl Acad Sci U S A; 2017 Mar; 114(10):E1885-E1894. PubMed ID: 28223506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequent hypermethylation of orphan CpG islands with enhancer activity in cancer.
    Bae MG; Kim JY; Choi JK
    BMC Med Genomics; 2016 Aug; 9 Suppl 1(Suppl 1):38. PubMed ID: 27534853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The functional epigenetic landscape of aberrant gene expression in molecular subgroups of newly diagnosed multiple myeloma.
    Choudhury SR; Ashby C; Tytarenko R; Bauer M; Wang Y; Deshpande S; Den J; Schinke C; Zangari M; Thanendrarajan S; Davies FE; van Rhee F; Morgan GJ; Walker BA
    J Hematol Oncol; 2020 Aug; 13(1):108. PubMed ID: 32762714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The recently identified modifier of murine metastable epialleles, Rearranged L-Myc Fusion, is involved in maintaining epigenetic marks at CpG island shores and enhancers.
    Harten SK; Oey H; Bourke LM; Bharti V; Isbel L; Daxinger L; Faou P; Robertson N; Matthews JM; Whitelaw E
    BMC Biol; 2015 Mar; 13():21. PubMed ID: 25857663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of KLF4 regulated genes in cancer cells reveals a role of DNA methylation in promoter- enhancer interactions.
    Oyinlade O; Wei S; Kammers K; Liu S; Wang S; Ma D; Huang ZY; Qian J; Zhu H; Wan J; Xia S
    Epigenetics; 2018; 13(7):751-768. PubMed ID: 30058478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5'-Hydroxymethylcytosine Precedes Loss of CpG Methylation in Enhancers and Genes Undergoing Activation in Cardiomyocyte Maturation.
    Kranzhöfer DK; Gilsbach R; Grüning BA; Backofen R; Nührenberg TG; Hein L
    PLoS One; 2016; 11(11):e0166575. PubMed ID: 27851806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developmentally linked human DNA hypermethylation is associated with down-modulation, repression, and upregulation of transcription.
    Baribault C; Ehrlich KC; Ponnaluri VKC; Pradhan S; Lacey M; Ehrlich M
    Epigenetics; 2018; 13(3):275-289. PubMed ID: 29498561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An integrated genomics analysis of epigenetic subtypes in human breast tumors links DNA methylation patterns to chromatin states in normal mammary cells.
    Holm K; Staaf J; Lauss M; Aine M; Lindgren D; Bendahl PO; Vallon-Christersson J; Barkardottir RB; Höglund M; Borg Å; Jönsson G; Ringnér M
    Breast Cancer Res; 2016 Feb; 18(1):27. PubMed ID: 26923702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide DNA methylation analysis reveals molecular subtypes of pancreatic cancer.
    Mishra NK; Guda C
    Oncotarget; 2017 Apr; 8(17):28990-29012. PubMed ID: 28423671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
    Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Base-pair resolution DNA methylation sequencing reveals profoundly divergent epigenetic landscapes in acute myeloid leukemia.
    Akalin A; Garrett-Bakelman FE; Kormaksson M; Busuttil J; Zhang L; Khrebtukova I; Milne TA; Huang Y; Biswas D; Hess JL; Allis CD; Roeder RG; Valk PJ; Löwenberg B; Delwel R; Fernandez HF; Paietta E; Tallman MS; Schroth GP; Mason CE; Melnick A; Figueroa ME
    PLoS Genet; 2012; 8(6):e1002781. PubMed ID: 22737091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypomethylation coordinates antagonistically with hypermethylation in cancer development: a case study of leukemia.
    Kushwaha G; Dozmorov M; Wren JD; Qiu J; Shi H; Xu D
    Hum Genomics; 2016 Jul; 10 Suppl 2(Suppl 2):18. PubMed ID: 27461342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenome-wide analysis reveals specific DNA hypermethylation of T cells during human hematopoietic differentiation.
    Tejedor JR; Bueno C; Cobo I; Bayón GF; Prieto C; Mangas C; Pérez RF; Santamarina P; Urdinguio RG; Menéndez P; Fraga MF; Fernández AF
    Epigenomics; 2018 Jul; 10(7):903-923. PubMed ID: 29620943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide methylation sequencing of paired primary and metastatic cell lines identifies common DNA methylation changes and a role for EBF3 as a candidate epigenetic driver of melanoma metastasis.
    Chatterjee A; Stockwell PA; Ahn A; Rodger EJ; Leichter AL; Eccles MR
    Oncotarget; 2017 Jan; 8(4):6085-6101. PubMed ID: 28030832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A proof-of-concept study for the pathogenetic role of enhancer hypomethylation of MYBPHL in multiple myeloma.
    Wong KY; Morgan GJ; Boyle EM; Cheng ASL; Yip KY; Chim CS
    Sci Rep; 2021 Mar; 11(1):7009. PubMed ID: 33772052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights into epigenetic regulation of microRNA-155 expression in multiple myeloma.
    Krzeminski P; Sarasquete ME; Misiewicz-Krzeminska I; Corral R; Corchete LA; Martín AA; García-Sanz R; San Miguel JF; Gutiérrez NC
    Biochim Biophys Acta; 2015 Mar; 1849(3):353-66. PubMed ID: 25497370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global DNA methylation profiling reveals new insights into epigenetically deregulated protein coding and long noncoding RNAs in CLL.
    Subhash S; Andersson PO; Kosalai ST; Kanduri C; Kanduri M
    Clin Epigenetics; 2016; 8():106. PubMed ID: 27777635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.